News & Press Releases

Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.  

Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.  

Mergermarket recently featured insights from Cheryl Reicin, Life Sciences Practice Co-chair, in an article discussing a potential 2026 rebound in M&A activity across the contract development and manufacturing organization (CDMO) sector, which provides outsourced development and manufacturing services to biopharma and medical‑device companies. 

Mintz advised the underwriters in connection with Eupraxia Pharmaceuticals’ $63.2 million public offering.

Mintz advised Vercept, a Seattle-based computer-use AI startup, in its sale to Anthropic, the leading AI safety and research company developing frontier-scale models and best known for its Claude family of large language models (LLMs). 

Communications Daily featured insights from Member Esteban Morales in an article about a ruling from the 5th U.S. Circuit Court of Appeals which said that despite an FCC ruling that required prior written consent for telemarketing calls, the Telephone Consumer Protection Act indicates that oral consent is enough.